Busulfan
ASCT1221
Phase 2 small_molecule completed
Quick answer
Busulfan for Juvenile Myelomonocytic Leukemia is a Phase 2 program (small_molecule) at Children's Hospital of Fudan University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Children's Hospital of Fudan University
- Indication
- Juvenile Myelomonocytic Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed